RSS

MeiraGTx

The UCL Technology Fund has revealed that one of its investments, MeiraGTx — a clinical stage gene therapy company — has raised $75 million of gross proceeds upon the closing of its initial public offering (IPO) earlier this year. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

UK-based synthetic biology company, Oxford Genetics, has established a new agreement with clinical-stage gene therapy company, MeiraGTx, for the development of novel adeno-associated virus (AAV) vectors. more

News